Tracon Pharmaceuticals, Inc. (CIK: 0001394319) EDGAR, Information, Filings... CompaniesBIO.Com

Tracon Pharmaceuticals, Inc.

Mailing address
4350 LA JOLLA VILLAGE DRIVE, SUITE 800, San Diego, Delaware, 92122
Phone
858-550-0780
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Tracon Pharmaceuticals, Inc. (CIK: 0001394319) is an American company incorporated in the state of California. Head office is located at 4350 LA JOLLA VILLAGE DRIVE, SUITE 800, San Diego, California, 92122. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Tracon Pharmaceuticals, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Tracon Pharmaceuticals Inc from 2007-22-Mar to 2014-15-Sep

Owner	Filings	Transaction Date	Type of Owner
Adams Bonne J.	0001965232	Feb-01-2023	officer: Chief Operating Officer
Lam Carol C.	0001410236	Oct-12-2021	director
Johnson-Pratt Lisa	0001849760	Mar-02-2021	director
Shahrestani Neil	0001824857	Sep-04-2020	10 percent owner, other: Member of 10% Group
Ikarian Healthcare Master Fund, L.P.	0001824870	Sep-04-2020	10 percent owner, other: Member of 10% Group
Ikarian Capital, LLC	0001778253	Sep-03-2020	10 percent owner, other: Member of 10% Group
Chart Westcott Living Trust	0001825179	Sep-03-2020	10 percent owner, other: Member of 10% Group
Ikarian Healthcare Fund GP, L.P.	0001825313	Sep-03-2020	10 percent owner, other: Member of 10% Group
Opaleye Management Inc.	0001595855	Aug-27-2020	10 percent owner
PELLETIER SAUNDRA L	0001251371	Mar-15-2020	director
Brown Scott B.	0001789822	Sep-18-2019	officer: Chief Accounting Officer (PAO)
Puissance Life Science Opportunities Fund VI	0001760460	Nov-29-2018	10 percent owner
WIGGINS MARK C	0001236540	May-29-2018	officer: Chief Business Officer
Wang Theodore T	0001694061	Apr-06-2018	director, 10 percent owner
Puissance Capital Management LP	0001658437	Mar-27-2018	10 percent owner
Puissance Capital Management (GP) LLC	0001695339	Mar-27-2018	10 percent owner
Puissance Capital Fund (GP) LLC	0001695347	Mar-27-2018	10 percent owner
Puissance Cross-Border Opportunities IV LLC	0001718140	Mar-27-2018	10 percent owner
Puissance Cross-Border Opportunities V LLC	0001733439	Mar-27-2018	10 percent owner
SHAZER RONALD L	0001654970	Oct-05-2015	officer: Chief Medical Officer
WORLAND STEPHEN T	0001283307	Feb-25-2015	director
CSA Biotechnology Fund I, llc	0001400426	Feb-04-2015	10 percent owner
BROOKLINE TRACON INVESTMENT FUND LLC	0001448374	Feb-04-2015	10 percent owner
BARRIS PETER J	0001005561	Jan-29-2015	10 percent owner
BARRETT M JAMES	0001219855	Jan-29-2015	10 percent owner
MOTT DAVID M	0001219871	Jan-29-2015	10 percent owner
KERINS PATRICK J	0001235112	Jan-29-2015	10 percent owner
SANDELL SCOTT D	0001237289	Jan-29-2015	10 percent owner
MATTINGLY MARTIN A	0001265782	Jan-29-2015	director
LARUE WILLIAM R	0001265784	Jan-29-2015	director
KOLLURI KRISHNA KITTU	0001270521	Jan-29-2015	10 percent owner
BASKETT FOREST	0001277631	Jan-29-2015	10 percent owner
DRANT RYAN D	0001302106	Jan-29-2015	10 percent owner
Weller Harry R	0001362942	Jan-29-2015	10 percent owner
Hozoji Hironori	0001377935	Jan-29-2015	director
Twiford J Rainer	0001405588	Jan-29-2015	director
CSA Biotechnology Fund II, LLC	0001477399	Jan-29-2015	10 percent owner
Viswanathan Ravi	0001479386	Jan-29-2015	10 percent owner
Brookline Tracon Investment Fund II, LLC	0001484011	Jan-29-2015	10 percent owner
New Enterprise Associates 14, L.P.	0001544328	Jan-29-2015	10 percent owner
NEA Partners 14, L.P.	0001551531	Jan-29-2015	10 percent owner
NEA 14 GP, LTD	0001551532	Jan-29-2015	10 percent owner
Walker Paul Edward	0001553150	Jan-29-2015	director
Sonsini Peter W.	0001559807	Jan-29-2015	10 percent owner
Florence Anthony A. Jr.	0001559827	Jan-29-2015	10 percent owner
JAFCO Super V3 Investment Limited Partnership	0001590442	Jan-29-2015	10 percent owner
Harada Kenji	0001591734	Jan-29-2015	director
THEUER CHARLES	0001631338	Jan-29-2015	director, officer: President and CEO
LOGAN H CASEY	0001631347	Jan-29-2015	officer: Chief Business Officer
BITAR PATRICIA L	0001631349	Jan-29-2014	officer: CFO

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Tracon Pharmaceuticals, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950170-24-102423 (34 Act) Size: KB	Aug-30-2024	001-36818 241270964
DEF 14A	Document	Definitive proxy statements Acc-no: 0000950170-24-102417 (34 Act) Size: KB	Aug-30-2024	001-36818 241270890
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-096403 (34 Act) Size: KB	Aug-13-2024	001-36818 241202680
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0000950170-24-094864 (34 Act) Size: KB	Aug-09-2024	001-36818 241193794
8-K	Document	Current report filing Acc-no: 0000950170-24-087947 (34 Act) Size: KB	Jul-30-2024	001-36818 241158335
25-NSE	Document	Acc-no: 0001354457-24-000515 (34 Act) Size: KB	Jul-19-2024	001-36818
8-K	Document	Current report filing Acc-no: 0000950170-24-083974 (34 Act) Size: KB	Jul-16-2024	001-36818 241120247
8-K	Document	Current report filing Acc-no: 0000950170-24-079290 (34 Act) Size: KB	Jul-01-2024	001-36818 241088414
8-K	Document	Current report filing Acc-no: 0000950170-24-076330 (34 Act) Size: KB	Jun-21-2024	001-36818 241061233
8-K	Document	Current report filing Acc-no: 0000950170-24-072265 (34 Act) Size: KB	Jun-12-2024	001-36818 241037581
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-059752 (34 Act) Size: KB	May-14-2024	001-36818 24945485
8-K	Document	Current report filing Acc-no: 0000950170-24-059509 (34 Act) Size: KB	May-14-2024	001-36818 24944197
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001415889-24-013032 ( Act) Size: 0 KB	May-13-2024
8-K	Document	Current report filing Acc-no: 0000950170-24-058206 (34 Act) Size: KB	May-13-2024	001-36818 24936928
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0000950170-24-044109 (33 Act) Size: KB	Apr-12-2024	333-278661 24842140
8-K	Document	Current report filing Acc-no: 0000950170-24-044096 (34 Act) Size: KB	Apr-12-2024	001-36818 24842049
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0000950170-24-044088 (33 Act) Size: KB	Apr-12-2024	333-263590 24841994
8-K	Document	Current report filing Acc-no: 0000950170-24-043154 (34 Act) Size: KB	Apr-10-2024	001-36818 24834296
8-K	Document	Current report filing Acc-no: 0000950170-24-042440 (34 Act) Size: KB	Apr-08-2024	001-36818 24828309
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-088469 (34 Act) Size: KB	Apr-05-2024	005-88629 24826587

Recent 20 filings. View all Tracon Pharmaceuticals, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Tracon Pharmaceuticals, Inc. overview
Tracon Pharmaceuticals, Inc. job
Tracon Pharmaceuticals, Inc. stock
Tracon Pharmaceuticals, Inc. ownership
Tracon Pharmaceuticals, Inc. CEO
Tracon Pharmaceuticals, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.